Factors Contributing To The Success Of Biotechnology Smes In Malaysia [TP248.195.M2 S243 2007 f rb]. by Abu Bakar, Saridan
 
 
FACTORS CONTRIBUTING TO THE SUCCESS OF 
BIOTECHNOLOGY SMEs IN MALAYSIA 
 
 
 
 
 
 
 
 
 
 
 
 
SARIDAN BIN ABU BAKAR 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
 
SEPTEMBER 2007 
 
 
 
 
 
 
 
 
FACTORS CONTRIBUTING TO THE SUCCESS OF BIOTECHNOLOGY 
SMEs IN MALAYSIA 
 
 
 
 
 
 
 
 
 
by 
 
 
 
 
 
 
 
 
SARIDAN BIN ABU BAKAR 
 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfillment of the requirements  
for the degree of  
Doctor of Philosophy 
 
 
 
 
 
 
 
SEPTEMBER 2007 
 
 
 ii
ACKNOWLEDGEMENTS 
 
In the name of Allah, the Most Beneficent, the Most Merciful 
 
This study has been a long and arduous journey, whose winding roads taught 
many a lesson, and whose end brought great joy to the heart.  It was a journey that 
was shared by many wonderful companions and mentors without whom this study 
would not see the light of day. Through their guidance, dedication and friendship, they 
have contributed in a great measure to the exploration and dissertation of this all 
important subject matter. In this respect, I am especially grateful to my main supervisor 
and mentor, Professor Mohamed Sulaiman, whose counsel and patience have inspired 
me in ways that they have equally benefited and equipped a generation of other 
scholars. My heartfelt gratitude also goes to Associate Professor Intan Osman for her 
inexhaustible energy in assisting me with the process and the review of my work. 
To the dean, Professor Dato’ Daing Nasir Ibrahim, and other members and staff 
of the Management School of USM, I would like to say a big thank you.  Even though 
Dato’ Daing once remarked that, “Doing PhD is a lonely journey…,” somehow, with 
people like Professor Mohamed Sulaiman, Associate Professor Intan Osman, 
Associate Professor Zainal Ariffin Ahmad, Professor Osman Mohamad, Associate 
Professor Yuserrie Zainuddin, Associate Professor T. Ramayah, Associate Professor 
Datin Rohani Hj Ali, Associate Professor Ishak Ismail, Dr Mahmod Sabri Haron, 
Associate Professor Fauziah Md Taib, Associate Professor Aizatt Hj Mohd Nasurdin, 
Dr Anees Janee Ali @ Hamid, Dr Siti Nabiha Abdul Khalid, Dr Nabsiah Abd Wahid, Dr. 
Ellisha Nasruddin, Kak Ton, Rusnah and Rizal around, my journey at the Business 
School was anything but lonely! 
Special thanks are due to Professor Asma Ismail (INFORMM), Professor 
Saringat Ba’i @ Baie (School of Pharmaceutical Science, USM) and Datuk Professor 
Mohamed Isa Abdul Majid (Pusat Racun Negara) for opening my doors to 
 iii
biotechnology entrepreneurship and biotechnology R&D commercialization;  to the nine 
biotechnology entrepreneurs for finding time in their hectic schedules to share their 
thoughts and experiences in the interviews; and to the 209 other biotechnology and 
non-biotechnology entrepreneur respondents for their professionalism and expertise in 
completing the quantitative part of this research.   
I would also like to thank the following individuals for their direct or indirect 
support of this research: Associate Professor Mohd Dahlan Ibrahim for data analysis, 
testing and questionnaire review; Prof Emeritus Dr Abdul Latif Ibrahim (UNISEL), En 
Ghazali Abdullah (NBD, MOSTI), Encik Yazid Md Jenin (NPC) and Emi Fatmawaty 
Ariffin (MIGHT) for materials on biotechnology and SMEs; Encik Zailani (UNISEL) and 
Encik Roslan Mohamad (SMIDEC) for SMEs directories; Dr Zainal Abidin Mohd Yusof 
(SIRIM), Professor Dr Hasanah M. Ghazali (UPM) and Dr Hassan Mat Daud (MARDI) 
for information on biotechnology entrepreneurs; Professor Mahfuz, Dr Rehana, 
Associate Professor Yuserrie and Associate Professor T. Ramayah for their attendance 
and valuable comments during my mock-up proposal and findings defenses. Associate 
Professor T. Ramayah has, in addition, been instrumental in guiding me with data 
analysis. To Associate Professor Zainal Ariffin, I thank him for the invaluable comments 
on the contents of this thesis and APA formatting. My gratitude also goes to Dr 
Rosmimah Mohd. Roslin (UiTM) for NVIVO 7 Qualitative Data Analysis software and Dr 
Mohd Hassan Mohd Osman (UTM) for his thesis on high technology SMEs in Malaysia. 
My appreciation would not be complete without mentioning my colleagues at 
the UiTM, in particular, those from the MEDEC and business faculty; and my PhD 
colleagues at the USM, for their constant encouragement: Datin Norela Nuruddin, Tuan 
Haji Basuni Hamim, Tuan Hj Ramli Raya, Ali Bahari, Azimi, Hanafi, Dr Norhana 
Salamudin, Dr Hayati Dahan, Professor Faridah Hassan, Dr Rokiah Hassan, Puteri 
Norashikin Mohamad, Rizal, Doblin, Bidin Chee, Bapak Anto, Roaimah, Nik Ramli, 
Maznah and many others, whose names are not mentioned here. 
 iv
Finally, I would like to acknowledge the contributions of my own family 
members: to my late grandmother, Hajjah Aishah Abdullah, for her love in raising me 
up and my early introduction to education;  to my mother, Hajah Zainab Yahaya, whom 
I get to meet more often when I drop by for curry mee during my regular trips to USM; 
to my sister-in-law, Toh Puan Zakiah Che Din, for her graciousness in providing me 
accommodation at her Laketown Villa in Bukit Merah during my stay in USM; to my 
wife, Nura Che Din and our two boys, Adam and Adeel, for their patience and 
understanding. To my late father, Allahyarham Hj Abu Bakar Budin, who passed away 
at the early stage of this study, I hereby dedicate this thesis. 
 
Wa billah hi taufiq wal hidayah. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v
DEDICATION 
 
 
 
 
 
To my father, 
Who taught me 
Everything 
I ever needed to know 
About living 
An ethical life. 
 
 
 
 
 vi
TABLE OF CONTENTS 
Page 
 
ACKNOWLEDGEMENTS ii 
TABLE OF CONTENTS vi 
LIST OF TABLES xiv 
LIST OF FIGURES xvi 
ABSTRAK xviii 
ABSTRACT xix 
CHAPTER 1 : INTRODUCTION   
1.1 General   1 
1.2 Significance of the Research 5 
1.3 Problem Statement   8 
1.4 Research Questions 9 
1.5 Research Objectives 9 
1.6 Organization of the Thesis 10 
1.7 Scope 11 
1.8 Definition of Key Terms 11 
1.9 Biotechnology 18 
1.10 Biotechnology in Malaysia 19 
1.11 Malaysian Biotechnology Policy 20 
1.12 Biotechnology Business 21 
1.13 Biotechnology SMEs 21 
1.14 Summary 24 
   
CHAPTER 2 : LITERATURE REVIEW  
2.1 Introduction 25 
2.2 Differences between Biotechnology and Non-Biotechnology 
SMEs 
25 
 2.2.1   Knowledge-based Resources 26 
 2.2.1.1   Education 26 
 2.2.1.2   Functional Experience 27 
 2.2.2   Entrepreneurs Age 28 
 2.2.3   Previous Sector Experience 28 
 2.2.4   Access to Financial Capital 29 
 2.2.5   Linkages 31 
2.3 Factors Contributing to Biotechnology SMEs success 34 
 vii
 2.3.1     The Importance of Success 35 
 2.3.2  The Measurement of Success 36 
 2.3.3  Dependent Variable:  Enterprise Success 38 
 2.3.3.1   Financial Profitability 38 
 2.3.3.2   Enterprise Growth 47 
 2.3.3.3   Satisfaction 47 
 2.3.3.4  Enterprise Success as Dependent Variable in 
this Research 
48 
 2.3.4  Independent Variables 49 
 2.3.4.1   Organizational Structure 50 
 2.3.4.1.1     Organizational Structure and SMEs 
success 
52 
 2.3.4.1.2      Moderating Role of Environment 54 
 2.3.4.1.3     Organization Structure as an 
Independent Variable in this 
Research 
58 
 2.3.4.2  Enterprise Strategies 59 
 2.3.4.2.1 Innovation Activities 59 
 2.3.4.2.1.1     Innovation Activities 
and SMEs Success 
60 
 2.3.4.2.1.2     Moderating Role of 
Environment 
62 
 2.3.4.2.1.3     Innovation Activities 
as an Independent 
Variable in this 
Research 
63 
 2.3.4.2.2  Linkages 64 
 2.3.4.2.2.1     Linkages and SMEs 
Success 
65 
 2.3.4.2.2.2     Moderating Role of 
Environment 
68 
 2.3.4.2.2.3     Linkages as an 
Independent Variable 
in this Research 
68 
 2.3.5   Moderating Variable 69 
 2.3.5.1    The External Environment 69 
 2.3.6   Control Variables  71 
 2.3.6.1   Entrepreneur Demographic Characteristics 71 
 2.3.6.1.1   Gender 71 
 2.3.6.1.2   Entrepreneur Age 72 
 2.3.6.1.3   Family History 73 
 viii
 2.3.6.1.4   Motivation 74 
 2.3.6.2   The Enterprise Demographic Characteristics 75 
 2.3.6.2.1   Enterprise Age 75 
 2.3.6.2.2   Enterprise Size 78 
 2.3.6.2.3   Location 80 
 2.3.6.2.4   Legal Form 81 
 2.3.6.2.5   Ownership 82 
 2.3.7   Summary 82 
   
CHAPTER 3 :  CONCEPTUAL FRAMEWORK, RESEARCH DESIGN 
AND METHODOLOGY 
 
3.1 Introduction   84 
3.2 Defining Biotechnology SMEs and non-Biotechnology SMEs   84 
3.3 Conceptual Framework 86 
3.4 Unit of Analysis 86 
3.5 Research Approach 87 
3.6 Research Design 100 
 3.6.1    Mixed Methods Research Rationale 100 
 3.6.2   Qualitative Study 103 
 3.6.3   Quantitative Study 104 
3.7 Summary 104 
   
CHAPTER 4 : METHODOLOGY FOR QUALITATIVE STUDY   
4.1 Introduction 106 
 4.1.1   Methodology   106 
            4.1.1.1   Grounded Theory, Phenomenology and 
Ethnography 
106 
4.2 Qualitative Study Methodology Rationale 109 
4.3 Data Collection 111 
 4.3.1   In-depth Interview 112 
 4.3.2   Field Notes 115 
 4.3.3   The Researcher as Instrument  117 
 4.3.4   Sampling 118 
 4.3.5   Respondents Selection and Process 119 
4.4 Validity and Trustworthiness of the Study 120 
4.5 Summary 123 
   
   
 ix
CHAPTER 5 : FINDINGS OF QUALITATIVE STUDY   
5.1 Introduction 124 
5.2 Results of Cross Case Analysis 124 
5.3 Entrepreneur’s Demographic Characteristics 125 
 5.3.1   Age 125 
 5.3.1.1   Young Age 125 
 5.3.1.2   Senior Age 127 
 5.3.2   Family History 128 
 5.3.3   Motivation 129 
5.4 Knowledge-based Resources 129 
 5.4.1   Education 130 
 5.4.2   Functional Experience 130 
 5.4.2.1   Management Experience 131 
 5.4.3   Training 131 
 5.4.3.1   Training Received 132 
 5.4.3.2   Continuous Learning 133 
 5.4.3.2.1   Continuous Training 133 
 5.4.3.2.2   Workshops, Short Courses and 
Seminars 
134 
 5.4.3.2.3   Trade Shows 136 
5.5 Organizational Structure 137 
5.6 Enterprise Image 138 
5.7 Enterprise Strategies 140 
 5.7.1   Access to Financial Capital 141 
 5.7.2   Government Assistances 143 
 5.7.3   Linkages 145 
 5.7.3.1   Linkages with Other Private Enterprises 146 
 5.7.3.2   Linkages with Academic Research Institutions 146 
 5.7.3.3   Linkages with Personal Researchers of the 
Academic Research Institutions 
148 
 5.7.4   Innovation Activities 151 
 5.7.4.1   R&D 151 
 5.7.4.2   Product Newness 155 
 5.7.4.3   Product Uniqueness 155 
5.8 Other Enterprise Strategies 156 
 5.8.1   Vertical Integration 157 
 5.8.3   GMP Compliance 160 
 5.8.4   Halal Certification 165 
 x
5.9 Enterprise Success 166 
 5.9.1   Financial Profitability 167 
 5.9.2   Enterprise Growth 168 
 5.9.2.1   Growth in Sales 171 
 5.9.3   Satisfaction 172 
5.10 Level of Competition 174 
5.11 Analysis 176 
 5.11.1   Data Analysis 177 
 5.11.2   Emergent Themes 184 
 5.11.3   Enterprise Image 187 
 5.11.3.1  Enterprise Image and SMEs Success 189 
 5.11.3.2  Moderating Role of Environment 191 
 5.11.3.3  Enterprise Image as an Independent Variable 
in this Research 
192 
 5.11.4   Vertical Integration 194 
 5.11.4.1  Vertical Integration and SMEs Success 195 
 5.11.4.2  Moderating Role of Environment 197 
 5.11.4.3  Vertical Integration as an Independent 
Variables in this Research 
199 
5.12 Summary 201 
   
CHAPTER 6 : METHODOLOGY FOR QUANTITATIVE STUDY   
6.1 Introduction 202 
6.2 Theoretical Framework 202 
6.3 Resource-based View of the Firm (RBV) 203 
6.4 Hypotheses Development 208 
 6.4.1    Differences between Biotechnology and Non-
Biotechnology SMEs 
  208 
 6.4.2    Relationship between Organizational Structure, 
Innovation Activities, Linkages, Vertical Integration 
Strategy and Enterprise Image with SMEs Success 
  211 
 6.4.3    Intensity of Competition moderates the Relationship 
between Organizational Structure, Innovation Activities, 
Linkages, Vertical Integration Strategy and Enterprise 
Image with SMEs Success 
  219 
6.5 Designing and Validating Survey Instrument 226 
 6.5.1   Questionnaire Design 226 
 6.5.1.1   Dependent Variable: Enterprise Success 226 
 6.5.1.1.1   Financial Profitability 226 
 6.5.1.1.2   Enterprise Growth 227 
 xi
 6.5.1.1.3   Satisfaction 227 
 6.5.1.2   Independent Variables 227 
 6.5.1.2.1   Knowledge-based Resources 227 
 6.5.1.2.2   Organizational Structure 228 
 6.5.1.2.3   Access to Financial Capital 228 
 6.5.1.2.4   Innovation Activities 228 
 6.5.1.2.5   Enterprise Linkages 229 
 6.5.1.2.6   Government Assistances 230 
 6.5.1.2.7   Vertical Integration Strategy 230 
 6.5.1.2.8   Enterprise Image 231 
 6.5.1.3   Moderating Variable: External Environment 231 
 6.5.1.4   Control Variables 232 
 6.5.1.5   Respondent’s  Comment 232 
6.6 Pilot Test 233 
 6.6.1   Instrument 233 
 6.6.2   Data Collection 233 
6.7 Method of Analysis 237 
6.8 Survey 238 
 6.8.1   Sampling Frame 238 
 6.8.1.1   SMIDEC Directory 239 
 6.8.1.2   NPCB Directory 240 
 6.8.1.3   PURBATAMA Directory 240 
 6.8.1.4   NBD Directory 241 
 6.8.1.5   BiotecCorp Directory 241 
 6.8.1.6   MOPI 242 
 6.8.2   Sampling Technique 245 
 6.8.3   Data Collection 248 
6.9 Summary 253 
   
CHAPTER 7 : FINDINGS OF QUANTITATIVE STUDY   
7.1 Introduction 254 
7.2 Data Collection 254 
7.3 Non-Response Bias Analysis 254 
7.4 Respondent’s Profile 256 
7.5 Enterprise Characteristics 265 
7.6 Goodness of Measures 271 
 7.6.1     Factor Analysis 273 
 xii
 7.6.2     Scale Reliability 278 
 7.6.3     Modified Research Framework for Factors Contributing 
to the Success of Biotechnology SMEs in Malaysia 
after Factor Analysis 
278 
 7.6.4     Hypotheses Restatement 279 
 7.6.5     Analyses of Dependent and Independent Variables 283 
 7.6.5.1   Correlation Analysis 283 
7.7 Hypotheses Testing 284 
 7.7.1 Differences between Biotechnology and non-
Biotechnology SMEs 
284 
 7.7.2 Relationship between Enterprise Factors and 
Biotechnology SMEs Success 
291 
 7.7.3   Moderating Effect of Competitive Environment on the 
Relationship between Organizational Structure, 
Enterprise Image and Strategies; and Enterprise 
Success. 
297 
7.8 Summary 308 
  
CHAPTER 8: DISCUSSION AND CONCLUSION  
8.1 Introduction 312 
8.2 Recapitulation of Research Findings 312 
8.3 Discussion 316 
 8.3.1     Differences between Biotechnology and non-
Biotechnology SMEs 
317 
 8.3.2     Differences in Factors Contributing to Enterprise 
Success between Biotechnology and non-
Biotechnology SMEs 
320 
 8.3.3     The Effect of Competitive Environment in Moderating 
the Relationship between Organizational Structure, 
Image and Enterprise Strategies for Biotechnology and 
non-Biotechnology SMEs 
329 
8.4 Theoretical Contributions 343 
8.5 Practical Contributions 345 
8.6 Limitations 349 
8.7 Suggestions Future Research Directions 350 
8.8 Conclusion 351 
   
REFERENCES  
  
 
 xiii
APPENDICES  
Appendix A Definition of Small and Medium Enterprises in Malaysia  
Appendix B Malaysian Biotechnology Policy  
Appendix C Qualitative Interview Guide  
Appendix D Introductory Letter for Qualitative Interview  
Appendix E Confirmation Letter  
Appendix F Interview Descriptions  
Appendix G Questionnaire  
Appendix H Cover Letter for Biotechnology SMEs  
Appendix I Cover Letter for non-Biotechnology SMEs  
Appendix J Chi-Square Analysis on Entrepreneur and Enterprise 
Demographic Characteristics for Early and Late 
Responses 
 
Appendix K T-Test Analysis on Main Variables for Early and Late 
Responses 
 
Appendix L Summary of Normality Test  
Appendix M Multicollinearity Analysis  
Appendix N Factor Analysis of Independent Variables  
Appendix O Factor Analysis of Moderating Variable  
Appendix P Factor Analysis of Dependent Variables  
Appendix Q Chi-Square Analysis on Research Variables   
Appendix R Independent Sample t-test on Research Variables  
Appendix S Regression Analysis of Factors Contributing to 
Biotechnology SMEs Success 
 
Appendix T Regression Analysis of Factors Contributing to non-
Biotechnology SMEs Success     
 
Appendix U     Multiple Hierarchical Regression Results of Control 
Variables, Organizational Structure, Image and 
Enterprise Strategies; on Success for non-
Biotechnology SMEs 
 
Appendix V     Multiple Hierarchical Regression Results of 
Competitive Environment as a Moderator in the 
Relationship between Organizational Structure, 
Enterprise Image and Strategies; on Success for non-
Biotechnology SMEs 
 
 
 
 
 
 
 
 
 
 
 xiv
LIST OF TABLES 
 
Page 
 
1.1 Development Expenditure and Allocation for Biotechnology 
under the Ninth Malaysia Plan (2006 to 2010)  
3 
1.2 Areas of Biotechnology Business   22 
2.1 Selected Studies on the Success Measurement of 
Biotechnology SMEs 
  39 
2.2 Selected Studies on the Success Measurement of Technology-
based SMEs  
  41 
2.3 Studies on the Success Measurement of Non-Biotechnology 
and Non-Technology-based SMEs 
  43 
2.4 Success Measurements of Biotechnology SMEs    49 
2.5 Entrepreneur Factors Related To SMEs Success   76 
2.6 Enterprise Factors Related To SMEs Success   79 
3.1 Selected Studies Utilizing Quantitative Method Approach 89 
3.2 Selected Studies Utilizing Qualitative Method Approach 91 
3.3 Selected Studies Utilizing Mixed Methods Approach 92 
3.4 Characteristics of Quantitative and Qualitative Methods in the 
Process of Research 
94 
4.1 Code Names for Respondent in Qualitative Study 116 
5.1 Themes from the Interview Transcripts 180 
5.2 Integration of Themes  183 
5.3 Tree Node for Entrepreneur’s Demographic Characteristics 184 
5.4 Tree Nodes from  Interview Transcripts 185 
6.1 Measures Summary 234 
6.2 Data Analysis Techniques 237 
6.3 Biotechnology SMEs in SMIDEC Directory 239 
6.4 Biotechnology SMEs in NPCB Directory 240 
6.5 Biotechnology enterprises in NBD Directory 241 
6.6 Biotechnology enterprises in BiotechCorp Directory 242 
6.7 Biotechnology SMEs in the Sampling Frame 243 
6.8 List of Biotechnology SMEs in Malaysia 244 
6.9 List of Non-Biotechnology SMEs in SMIDEC Directory 245 
6.10 Sample of non-Biotechnology SMEs for the Survey 247 
6.11 List of Conferences and Seminar Attended in 2004 and 2005 250 
6.12 Reasons for Returned Letters 252 
7.1 Data Collection 255 
 xv
7.2 Non-Responses Bias Analysis on Entrepreneur’s and 
Enterprise Demographic Variables for Early and Late 
Responses 
257 
7.3 Non-Responses Bias Analysis on Main Variables for Early and 
Late Responses 
258 
7.4 Respondents’ Profile 259 
7.5 Prior Training Received 260 
7.6 Continuous Training Received 261 
7.7 Prior Sector Experience 262 
7.8 Previous Enterprise Ownership Experience 263 
7.9 Years of Functional Experience 263 
7.10 Inception of Entrepreneurship   264 
7.11 Share Ownership of the Enterprise 265 
7.12 Enterprise Characteristics 266 
7.13 Respondents by Industry 268 
7.14 Size of the Enterprises based on Number of Full-time 
Employees and Annual Sales 
269 
7.15 Location  of the Enterprises 270 
7.16 Summary of Normality Analyses 272 
7.17 Results of Factor Analysis for Independent Variables 274 
7.18 Results of Factor Analysis for Moderating Variables 277 
7.19 Results of Factor Analysis for Dependent Variables 277 
7.20 Reliability Coefficients for the Major Variables 279 
7.21 Correlation between Variables  285 
7.22 Chi-square Test on Differences between biotechnology and 
non-Biotechnology SMEs  
286 
7.23 T-test on Differences  between biotechnology and non-
Biotechnology SMEs 
287 
7.24 Multiple hierarchical regression results of control variables, 
organizational structure, image and enterprise strategies; on 
success of Biotechnology SMEs 
293 
7.25 Multiple hierarchical regression results of competitive 
environment as a moderator in the relationships between 
organizational structure, enterprise image and strategies; and 
the success of Biotechnology SMEs 
299 
7.26 Summary Results of Hypotheses Testing 309 
8.1 Source of Financing for Biotechnology SMEs 318 
 
 
 xvi
LIST OF FIGURES 
 
Page 
 
1.1 Malaysia’s Biotechnology Focus Areas 4 
3.1 Proposed Research Framework for Factors Contributing to the 
Success of Biotechnology SMEs in Malaysia 
86 
3.2 Sequential Exploratory Design 103 
6.1 
 
Theoretical Frameworks of Factors Contributing to the Success 
of Biotechnology SMEs in Malaysia 
203 
7.1 Modified Research Framework for Factors Contributing to the 
Success of Biotechnology SMEs in Malaysia after Factor 
Analysis 
280 
7.2 Moderating Effects of Competitive Environment on the 
Relationship between Organizational Structure and 
biotechnology SMEs success. 
303 
7.3 Moderating Effects of Competitive Environment on the 
Relationship between Enterprise Image and Biotechnology 
SMEs success. 
304 
7.4 Moderating Effects of Competitive Environment on the 
Relationship between Enterprise Linkages and Biotechnology 
SMEs success. 
306 
7.5 Moderating Effects of Competitive Environment on the 
Relationship between Internal and External Networking, and 
Biotechnology SMEs success. 
307 
 
 
 xvii
FAKTOR-FAKTOR PENYUMBANG KEJAYAAN PKS BIOTEKNOLOGI DI 
MALAYSIA 
 
ABSTRAK 
Bioteknologi merupakan gabungan di antara biologi dan teknologi.  Bioteknologi 
telah dikenalpasti sebagai enjin pemacu pembangunan bagi Malaysia ke arah negara 
mencapai status negara maju pada tahun 2020.  Perusahaan kecil dan sederhana 
(PKS) bioteknologi merupakan penggerak utama bidang bioteknologi di Malaysia.  
Jesteru, kejayaan PKS bioteknologi adalah penting bagi menjamin kejayaan sektor 
bioteknologi di Malaysia.  Menyedari pentingnya peranan yang dimainkan oleh PKS 
bioteknologi kepada kemakmuran ekonomi negara, penyelidian ini bertujuan untuk 
mengenalpasti faktor-faktor penyumbang kepada kejayaan PKS bioteknologi di 
Malaysia.  Dalam perkara ini, penyelidikan-penyelidikan terdahulu telah dirujuk bagi 
mewujudkan kerangka kerja penyelidikan.  Penyelidikan ini melibatkan gabungan dua 
kaedah penyelidikan berturutan iaitu kualitatif dan ikuti dengan kuantitatif.  Kajian 
kualitatif dijalankan mengikut pendekatan teori ‘grounded’ untuk mengenalpasti faktor-
faktor penyumbang kepada kejayaan PKS bioteknologi di Malaysia.  Kajian kualitatif 
melibatkan pengumpulan maklumat melalui temuduga separa berstruktur secara 
mendalam dengan sembilan usahawan bioteknologi yang mewakili 10 PKS 
bioteknologi di Malaysia.  Melalui kajian kualitatif, pembolehubah tidak bersandar baru 
ditambah kepada kerangka penyelidikan yang sebelum ini diwujudkan hanya melalui 
tinjauan literatur.  Kajian kuantitatif berikutnya dibuat dengan kaedah temuduga 
bersemuka dengan 103 responden bidang bioteknologi dan 106 bukan bioteknologi 
meggunakan borang soal selidik. 
Dapatan utama penyelidikan boleh dikelasifikasikan kepada tiga bahagian.  
Pertama, penyelidikan ini mendapati PKS bioteknologi dan bukan bioteknologi adalah 
berbeza.  Keputusan ujian ‘chi-square’ dan ‘t-test’ menunjukkan usahawan bioteknologi 
mempunyai pengalaman yang lebih di dalam sektor yang berkaitan dengan 
perusahaan yang dijalankan serta aktiviti-aktiviti penyelidikan dan pembangunan, 
 xviii
berbanding dengan usahawan bukan bioteknologi.  PKS bioteknologi juga lebih baru 
ditubuhkan dan lebih kecil berbanding dengan PKS bukan bioteknologi.  Namun begitu, 
PKS bioteknologi lebih banyak terlibat dengan aktiviti integrasi ke hadapan serta 
mempunyai imej perusahaan yang lebih baik.  PKS bioteknologi lebih sulit 
memperolehi sumber kewangan dari luar, tetapi mereka lebih banyak menerima 
bantuan-bantuan kerajaan.  Dalam aspek inovasi pula, PKS bioteknologi didapati 
kurang mengendalikan aktiviti inovasi sungguhpun menjalinkan hubungan yang lebih 
dengan institusi penyelidikan, penyelidik dan jaringan dengan lain-lain perniagaan 
persendirian berbanding dengan PKS bukan bioteknologi.  PKS bioteknologi secara 
umumnya berpandangan persekitaran luaran yang dihadapi adalah lebih stabil 
berbanding dengan suasana persaingan yang lebih sengit dihadapi oleh PKS bukan 
bioteknologi.  Perbezaan yang terakhir ialah dari segi kejayaan di mana kajian ini 
mendapati PKS bioteknologi lebih berjaya daripada PKS bukan bioteknologi.  Kedua, 
analisis berganda menunjukkan struktur organisasi yang organik, imej, jaringan 
perniagaan, strategi integrasi ke belakang dan aktititi-aktiviti inovasi adalah faktor 
penyumbang yang signifikan kepada kejayaan PKS bioteknologi di Malaysia.  
Berikutnya yang ketiga, kajian ini juga mendapati dalam persekitaran luaran yang 
menghadapi persaingan yang sengit, struktur organisasi organik dan imej perusahaan 
yang tinggi adalah dua faktor utama penyumbang kepada kejayaan PKS  bioteknologi.  
Penyelidikan yang telah dijalankan ini akan dapat menyumbang meningkatkan lagi 
pengetahuan mengenai perusahaan sektor bioteknologi serta bidang keusahawanan 
secara keseluruhannya di Malaysia. 
 xix
 FACTORS CONTRIBUTING TO THE SUCCESS OF BIOTECHNOLOGY SMEs IN 
MALAYSIA 
 
ABSTRACT 
Biotechnology is the fusion of biology and technology.  It is a fascinating field 
that has been identified as the next engine of growth for Malaysia, one that will 
accelerate the country’s transformation into a highly industrialized nation by the year 
2020.  In Malaysia, biotechnology based small and medium enterprises (SMEs) are 
the main players in the emerging biotechnology sector. Their success is crucial to the 
growth, stability and general well-being of this sector. Realizing their critical role to 
the country’s economy, this research seeks to better understand the underlying 
factors that contribute to their success.  In the course of doing this, prior studies were 
referred to in the crafting of the initial research framework.  This empirical research is 
an exploratory study that employs a mixed methodology of sequential qualitative and 
quantitative investigations.  For the purpose of the qualitative study, the grounded 
theory approach was used to identify the factors that contribute to the success of 
biotechnology SMEs in Malaysia. Qualitative data from semi structured face-to-face 
in-depth interviews involving nine biotechnology entrepreneurs of 10 biotechnology 
SMEs in Malaysia were then obtained and used to further modify the initial research 
framework with the inclusion of two new variables.  For the quantitative study, a 
survey instrument was used in face-to-face interviews with 103 biotechnology and 
106 non-biotechnology respondents.  
The major findings of this research can be classified into three.  Firstly, this 
research found some significant differences between biotechnology and non-
biotechnology SMEs.  Results of chi-square and independent sample t-test, found 
that biotechnology entrepreneurs are significantly different from their non-
biotechnology counterparts in the areas of the owner-manager’s related sectoral 
experience and R&D activities. In these two areas, biotechnology entrepreneurs are 
found to be relatively more experienced. Other differences encompass the factors of 
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age, size, external financial capital access, government assistances, image, linkages, 
networking, integration, innovation and perception of the external environment. In 
general, biotechnology SMEs are newer and smaller. They are more forward 
integrated and have stronger image. Though they face a greater challenge to obtain 
external financial capital, they are at the receiving end of more government 
assistances.  In the area of innovation, they tend to lack behind the non-
biotechnology SMEs. Their innovation activities are less extensive by comparison, 
notwithstanding the array of linkages and networks that they have with academic 
research institutions, individual researchers and other private enterprises.  
Perception of their industries is also markedly different between the two SME groups. 
While the non-biotechnology SMEs tend to characterize their industries as robust and 
highly competitive, the biotechnology SMEs perceive a more stable competition in 
their own industry.  Finally, biotechnology SMEs are significantly more successful 
than non-biotechnology SMEs.  Secondly, based on two steps multiple hierarchical 
regression analysis, this research found organizational structure, enterprise image, 
internal and external networking; backward integration strategy, and innovation 
activities as being factors that significantly impact the success of Malaysian 
biotechnology SMEs.  Thirdly, results of four steps multiple hierarchical regression 
analysis finds organic organizational structure and strong image as having 
particularly strong influences on enterprise success when the intensity of competition 
is high.  Based on these research findings, this researcher puts forward 
recommendations for future research on biotechnology enterprises in Malaysia. It is 
the ardent hope of this researcher that these findings also help to elucidate an aspect 
of biotechnology to the existing body of knowledge, especially in the field of 
entrepreneurship study in Malaysia. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 General 
The Malaysian Government has identified biotechnology as the next engine of 
growth for the country. It has been identified as one of the five core technologies that 
will accelerate Malaysia’s transformation into a highly industrialized nation by 2020 
(Malaysia, 2001).  As stated by the Prime Minister of Malaysia, Datuk Seri Abdullah 
Ahmad Badawi, 
Biotechnology has great potential in Malaysia and it could be a catalyst for 
new growth areas in the country's economy as well as a source of new wealth 
and income for the people.  Biotech is useful in many areas - agriculture, 
livestock farming, herbal industry and traditional and modern medicine.  Its 
potential in the pharmaceutical industry is also unlimited (Syed Harun, 2004). 
 
Accordingly, Malaysia has wisely invested in biotechnology to achieve a rapid 
advancement in agriculture, human health and other relevant industrial sectors 
(BIOTEK, 2001).  As a first step, a biotechnology Expert Group was established in 
1984 by the National Council for Scientific Research and Development (NCSRD) 
under the auspices of its Agriculture Science Committee. This Group was asked to 
study the implications of biotechnology to the country, scope the current status, and 
make recommendations to the Council (Omar, 1990).  Among the recommendations 
that were put forth and taken up by the NCSRD, was the formation of the National 
Biotechnology Committee and its five sub-committees representing microbial, plant, 
industrial and environmental; medical and animal biotechnologies.  Later, under the 
5th Malaysia Plan (1986-1990), a special funding of RM5.45 million was approved by 
the government to boost biotechnology based projects (Malaysia, 1986).  Omar 
stated that during the period of 1988 to 1990, 22 biotechnology projects with a worth 
totalling RM2 million were financed by this fund (Omar, 1990). 
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In the 6th Malaysia Plan (1991-1995),  the government announced long-range 
plans to substantially expand resources in new and emerging technologies, 
particularly those that have a potential for optimal pay-offs (Malaysia, 1991).  The 
Plan stated that five key technology areas, including biotechnology had been 
identified for competence building, innovation enhancement, and expansion of niche 
area development of the domestic industries.  Other than biotechnology, the other 
areas were automated manufacturing technology (AMT), advanced materials, 
electronics, and information technology (IT).  The 6th Malaysia Plan (1991-1995) 
further identified biotechnology as having grown in importance as a key technology of 
the future through advances in molecular biology and genetic engineering.  
Biotechnology applications in Malaysia were evident in such diverse areas as 
agriculture, health, food and energy.  In these areas, Malaysia had acquired 
competency and institutional strength.  Realizing the great significance of 
biotechnology, the R&D component of the biotechnology sub-committee had 
proposed 25 projects at a cost of RM12.5 million under the 6th Malaysia Plan.  This 
amount represented more than a 100 percent increase from the previous 5th 
Malaysia Plan of RM5.45 million. 
 Moving forward, in the 7th Malaysia Plan (1996-2000), life science was 
introduced and clustered together with biotechnology as an advanced technology 
along with five others, namely, information technology and communication; 
microelectronics, advanced manufacturing technology, advanced materials and 
environment; and energy-related technologies. These were promoted by the 
government to create new investment opportunities for the economy as a whole 
(Malaysia, 1996).  A sum of RM 35 million was allocated for a partnership program 
with the Massachusetts Institute of Technology (MIT), of the USA.  Later, under the 
8th Malaysia Plan (2001-2005), a larger amount of allocation in the sum of RM100 
million was allocated for biotechnology research in the fields of agro-biotechnology, 
health care, and environmental and energy management (Malaysia, 2001).  The Plan 
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also laid down initiatives taken to identify and formulate research programs in 
genomics and molecular biology; pharmaceutical and nutraceutical biotechnology; as 
well as agro-biotechnology. 
Recently, the Malaysian government announced that under the Ninth 
Malaysia Plan (2006-2010), an allocation of over RM2 billion will be set aside for 
various biotechnology developments in the country (Malaysia, 2006). The breakdown 
of this allocation is shown in Table 1.1.  Almost half of the budget allocation (45.90 
percent) will cater for physical infrastructure development, while the remainder (54.10 
percent) will be allocated for soft infrastructure development, including R&D, 
commercialization and business development programmes.  
 
Table 1.1 
Development Expenditure and Allocation for Biotechnology under the Ninth Malaysia 
Plan (2006 to 2010)  
Programme 
8th Malaysia Plan 
Expenditure 
(RM Million) 
9th Malaysia Plan 
Allocation 
(RM Million) 
R&D 190.00 463.00 
Biotechnology R&D Initiatives 190.00 363.00 
Biotechnology Commercialization Fund          - 100.00 
Biotechnology Acquisition Programme          - 100.00 
Biotechnology Business Development 216.80 529.80 
Technology & IP Management   69.90 100.00 
Entrepreneurship Development          -   50.00 
Agro-biotechnology Projects   46.90   79.80 
Institutional Support and Equity 100.00 300.00 
Biotechnology Infrastructure 167.60    928.50
Total 574.40 2,021.30
 
Source: Malaysia (2006, p.  168). 
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As part of the initiative, the Malaysian Government plans to develop over 400 
BioNexus status companies by 2010 (Malaysia, 2006). These companies are 
harbingers of a new strategic thrust for the modern biotechnology sector in Malaysia.  
To date, the modern biotechnology sector is relatively young with fewer than 30 
enterprises, mostly established within the past decade (Ernst & Young, 2005).  These 
enterprises are involved in the areas of agriculture, healthcare and industrial 
biotechnologies.  In the future, Malaysia’s focus areas for biotechnology will be in the 
19 areas shown in Figure 1.1. 
 
 
 
 
Figure 1.1.  Malaysia’s biotechnology focus areas. 
Source: Malaysian Biotechnology Corporation [BiotechCorp], 2006). 
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Biotechnology is an extremely competitive field and has evolved 
predominantly in response to a market need for technologies and approaches that 
can speed up product development and reduce development costs.  The promise of 
biotechnology seems to have caught the imagination of many scientists, government 
authorities and investors around the world today. Countries in Asia such as 
Singapore, India and Malaysia are now intensely into developing their biotechnology 
centres (Heong, 2004).  However, the report commented that these countries might 
have been taken overboard by the sales pitch of biotechnology proponents, who 
often exaggerated the benefits of the technology and the wonders that techniques, 
such as genetic engineering, bring to people's lives.   
Aside from environmental and health risks and questions over the financial 
viability of investing in biotechnology, there is growing evidence that the technology is 
not benefiting people whose lives depend on it (Li, 2004). The Star report highlighted 
the experiences of cotton farmers in Indonesia and India who have not gained any 
benefits of higher yields, and hence better incomes, from genetically modified cotton.  
However, these evidences have not hampered countries around the world to 
set up their own biotechnology initiatives. According to Datuk Jamaluddin Jarjis, the 
Malaysian minister of Science, Technology and Innovation (MOSTI), Malaysia is 
committed to provide attractive incentive packages to biotechnology companies 
investing in the country (Syed Harun, 2004).  The New Straits Times (NST) report 
further stated that the package would include a wide spectrum of financing 
structures; including business-angle financing, venture-capital financing, debt 
ventures and technology banking.  Datuk Jamaluddin Jarjis has also offered 
biotechnology companies to conduct their clinical tests in the country (Jalil, 2004). 
 
1.2 Significance of the Research 
The Malaysian biotechnology sector is dominated by specialized 
biotechnology, agricultural, biopharmaceutical and bioinformatics SMEs, as well as 
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suppliers to the biotech industry (Biotechnology Information Centre Malaysia [BIC], 
2001).  The importance of SMEs in the development of the biotechnology sector in 
Malaysia suggests that an understanding of the success factors of these SMEs is 
crucial to the stability and health of the technology, and eventually the nation’s 
economy.  However, currently there are limited studies in Malaysia that determine the 
factors that contribute to the success of biotechnology SMEs.    In fact, despite their 
important role in the national economy, research on general SMEs too appears 
limited and neglected (Sulaiman & Hashim, 2000).  The extant literature indicates 
that SMEs have received minimal theoretical and empirical research attention as a 
serious field of study.  Moreover, according to Sulaiman and Hashim (2000), even 
though SMEs in Malaysia have, of late, attracted some degree of research attention, 
investigations on them are still relatively limited in scope and not integrated in nature.  
The focus has been mainly on observing, describing, and reporting their general profile; 
the personal characteristics of the owners; problems and constraints faced by them; 
and the assistance programmes provided by the government. The above authors 
found that research emphasis on SMEs’ management styles, their organisational 
structures, culture, stage of development, and their external environment has been 
rather limited.   
Fewer studies have been made to investigate the relevant theories of 
entrepreneurial achievements such as the personality traits of successful 
entrepreneurs and the competencies required for becoming successful 
entrepreneurs. The study of demographic characteristics and their relationships to 
SMEs performance appears to be likewise limited (Chee, 1986). 
Much interest has been shown on the factors contributing to the success of 
SMEs in general.  A number of studies in this area examined the entrepreneurial 
characteristics in order to explain the success or failure of firms (e.g., Hisrich & 
Brush, 1986).  Other studies (e.g., Hashim, 2002a) chose to delve into the enterprise 
factors for pointers of SMEs success.  In this regard, Hashim singled the adaptation 
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of strategy, distinctive capabilities, organizational structure, technology, 
organizational culture and firm characteristics as six factors related to the enterprise.   
Another important success factor relates to the external environment. Here, 
the external environment of the enterprise can be classified into two, namely, general 
and competitive environments (Miller & Dess, 1996).  The general environment 
consists of the political-legal, macroeconomic, socio-cultural, technological, 
demographic and global factors that might affect the organization’s activities.  On the 
other hand, the competitive environment consists of other specific organizations that 
are likely to influence the profitability of the enterprise, such as customers, suppliers 
and competitors.  It would seem from the above studies that the success of SMEs is 
highly dependent on the interrelationship of the three strategic factors; entrepreneur 
characteristics, enterprise factors and the external environment (Hashim, 2002a). 
The foregoing studies relate to SMEs in general. Despite their importance to 
the country’s economy, as evidenced by the huge budget allocation mentioned 
earlier, little empirical work has been done specifically on the biotechnology sector in 
Malaysia.  To the best of this researcher’s knowledge, only one study by Mohd 
Osman (2002) has been conducted thus far on high technology-based SMEs.  In his 
mixed methods study of growth determinants and constraints faced by high 
technology SMEs in Malaysia, Mohd Osman included 11 biotechnology SMEs in the 
sampled total of 86 respondents for the quantitative study.  From these 11 
biotechnology SMEs, six were further selected to participate in the next qualitative 
stage of his study.    
 In addition to the lack of specific study on biotechnology SMEs, little 
empirical research has also been conducted to explore the differences between 
biotechnology and non-biotechnology SMEs; and the specific success factors of 
biotechnology SMEs.  To mention the few studies on the differences between the two 
SMEs, these include those of Brierley (2001); Liebeskind, Oliver, Zucker and Brewer 
(1996); Lynskey (2004a); Lynskey (2004b); and Reuber and Fischer (1994). Of the 
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studies on biotechnology success factors, those of Kropp and Zolin (2005); and 
Sapienza, Manigart and Vermir (1996) focused on entrepreneur characteristics, while 
Audretsch (2001), Deeds and Rothaermel (2003); Folta, Cooper and Baik (2006); 
Hall and Bagchi-Sen (2002); Nilsson (2001), Niosi (2002), Stuart and Sorenson 
(2003); and Zahra (1996a) studied factors related to the enterprise.   
This research is an attempt to address the conundrum caused by the 
absence of a comprehensive treatment of all the factors found or suggested by 
earlier independent studies. It is the ardent belief of this researcher that if all the 
factors in these studies are simultaneously included within a single study, a more 
accurate assessment can be made of the relative impact of each of these factors on 
the success of biotechnology SMEs. This research, therefore, seeks to identify some 
of the more prominent differences between biotechnology and non-biotechnology 
SMEs in Malaysia; investigates the presumed effects of enterprise factors to the 
success of biotechnology SMEs in Malaysia; and to understand the role of perceived 
intensity of competition in moderating the relationship between enterprise factors and 
biotechnology SMEs success.   
 
1.3 Problem Statement 
This research is conducted in the context of the Malaysian biotechnology 
sector which has been receiving a great deal of attention from the Government.  
Based on literature precedence and a strategic approach, this study develops and 
presents an integrative framework for examining and understanding the strategic 
factors for managing biotechnology SMEs successfully in the Malaysian context. 
Malaysia’s efforts on biotechnology development have been dismally slow 
and hampered by a number of setbacks.  The biotechnology sector in Malaysia is still 
in its infancy and occupies a market share of less than 0.5 percent of the total 
biotechnology revenue in the Asia Pacific region (Rajen, 2006).  Its foray into big time 
biotechnology integration in May 2003 with the launching of the 80 ha BioValley has 
  9
thus far failed to materialize.  In addition, despite being listed as a mega-diversity 
nation and placed in number twelve in the world and fourth in Asia, behind India, 
China and Indonesia, biotechnology has not experienced significant success in 
Malaysia.   
In 2005, Malaysia was ranked ninth in the Ernst and Young Global 
Biotechnology Ranking for the Asia Pacific Region (Abu Bakar, 2005).  This ranking 
was based on the number of biotechnology companies, number of employees, 
revenue, R&D expenses, and financial and survival indices (Ernst & Young, 2005).  
The number of biotechnology enterprises was 475 as listed in various databases 
(Current Study).  Out of this, only 30 were classified as modern biotechnology 
enterprises (Ernst & Young, 2005).  Moreover, the recent Ninth Malaysia Plan (2006-
2010) further stated that the Malaysian biotechnology sector faces a challenging 
future with increasing global competition.  To be competitive, Malaysia biotechnology 
enterprises will need to identify and build upon niche products and services in 
appropriate parts of the global value chain.   
 
1.4 Research Questions 
This research attempts to answer the following major questions:  
• What are the differences between biotechnology and non-biotechnology 
SMEs in Malaysia? 
• What enterprise factors contribute to the success of biotechnology SMEs in 
Malaysia? 
• What is the effect of intensity of competition in moderating the relationship 
between enterprise factors and biotechnology SMEs success? 
 
1.5 Research Objectives 
The aim of this study is to contribute additional information to the existing 
body of knowledge that will help address the dismal situation of biotechnology 
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development in the country.  This research attempts to fill a gap in the existing 
literature, especially in Malaysia, by explicitly focusing on the differences between 
biotechnology and non-biotechnology SMEs, their success factors and the 
moderating effect of the intensity of competition.  More specifically, this research will 
address the following major objectives:  
• To identify differences between biotechnology and non-biotechnology SMEs 
in Malaysia. 
• To identify enterprise factors contributing to the success of biotechnology 
SMEs in Malaysia.  
• To investigate the effect of external environmental factor in moderating the 
relationship between enterprise factors and the success of biotechnology 
SMEs in Malaysia. 
 
1.6 Organization of the Thesis 
The contents of this thesis are organized into eight chapters.  Chapter 1 
provides a brief introduction to biotechnology, the need for research on biotechnology 
SMEs in Malaysia, research questions, research objectives, scope of the research, 
definition of key terms, an overview of the biotechnology sector in Malaysia, 
biotechnology businesses and biotechnology SMEs.  Chapter 2 reviews the extant 
literature on the differences between biotechnology and non-biotechnology SMEs, as 
well as the contributing factors to the success of biotechnology SMEs.  This chapter 
also discusses the success measurement of biotechnology SMEs.  Following the 
literature review, conceptual framework, research design, methodology and research 
methodology rationale are discussed in Chapter 3. The conceptual framework serves 
to link all known factors that contribute to the success of biotechnology SMEs in 
order to form the principal research focus.  Chapter 4 reports in detail on the 
methodology used in the qualitative study. The following Chapter 5 draws the 
findings of this qualitative study.  Chapter 6 is devoted to the quantitative study 
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methodology where the theoretical framework, underlying theory, details of each 
construct and the hypotheses derived from the theoretical framework are identified.  
Discussion on the measurement of different variables, analytical methods, and pilot 
testing is also included in this chapter.  Chapter 7 reports on the findings of the 
quantitative study which includes the respondents’ profiles, analyses of dependent 
and independent variables; and results of hypotheses testing.  Finally, Chapter 8 
draws the conclusions of this research with a summary and a discussion of the 
findings, research contributions, limitations as well as suggestions for future research 
directions.       
 
1.7 Scope 
This research is concerned with the differences between biotechnology and 
non-biotechnology SMEs; enterprise factors that contribute to the success of 
biotechnology SMEs; and the moderating effect of competitive environment on the 
relationship between enterprise factors and biotechnology SMEs success in 
Malaysia. It is conducted fully in Malaysia in the years 2005 to 2006 time period.  
Biotechnology SMEs are selected from those in the manufacturing of biomedical, 
agriculture and veterinary; food, environmental and industrial; and other 
biotechnology business activities listed in various directories in Malaysia. 
 
1.8 Definition of Key Terms 
1.8.1 Biotechnology 
Biotechnology may be defined in terms of the use of biological organisms for 
the attainment of commercial ends (Fransman, 1991).   
 
1.8.2 Small and Medium Enterprises (SMEs) 
According to the National SME Development Council (NSDC) an SME in 
Malaysia is defined as: 
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a. A small-sized enterprise in manufacturing (including agro-based and 
Manufacturing Related Services) with full-time employees of between 5 and 50, 
or an annual turnover of between RM250,000 and less than RM10 million. 
b. A medium-sized enterprise (including agro-based and Manufacturing Related 
Services) with full-time employees of between 51 and 150 or an annual 
turnover of between RM10 million and RM25 million  
 
These definitions are applied by all Government Ministries and Agencies 
involved in SME development as well as by the financial institutions (Bank Negara 
Malaysia, 2005).  In addition, a micro enterprise in manufacturing (including agro-
based and Manufacturing Related Services) is an enterprise with full-time employees 
of less than 5 or with an annual turnover of less than RM250,000.  Details of the 
SMEs definition in Malaysia are included in Appendix A. 
 
1.8.3 Biotechnology SMEs 
Biotechnology SMEs refer to small and medium enterprises that use 
biological organisms, through various biotechnological techniques (Smith, 1996), to 
develop products for human and animal in the area of biomedical, agriculture-
veterinary, food, environmental and industrial, and other biotechnology business 
activities (BIOTEK, 2001; National Pharmaceutical Control Bureau [NPCB], 2005; 
and Shahi, 2004). 
 
1.8.4 Technology based SMEs 
Technology-based SMEs are enterprises whose products depend largely on 
the application of scientific or technological knowledge, or are businesses whose 
activities embrace a significant technology component as a major source of 
competitive advantage (Brierley, 2001).  These businesses are generally located in 
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industries such as communication, IT, computing, biotechnology, electronics, and 
medical or life sciences.  
 
1.8.5 SMEs Success 
SMEs success refers to the effectiveness of an enterprise in accomplishing its 
objectives that are measured by financial profitability, growth and satisfaction. 
 
1.8.6 Financial Profitability 
The profitability measure is computed by averaging the financial 
profitability ratios of return on total assets (ROA), return on total equities (ROE) 
and return on sales (ROS) for the year 2004.  ROA is operationalized by dividing 
net profit by the total assets in 2004 (Net Profit/Total Assets).  ROE is net profit 
divided by total equities in 2004 (Net Profit/Total Equities).  Meanwhile, ROS is 
operationalized by dividing net profit by total sales in 2004 (Net Profit/Total Sales)  
This research adopts the business performance composite measure (BPCM) as 
the mean values of ROA, ROE and ROS (Hashim, Wafa & Sulaiman, 2004; Lee, 
1987).  Thus, BPCM is operationaized as; 1/3 (ROE + ROS + ROA). 
 
1.8.7 Enterprise Growth 
The enterprise growth is operationalized as the average sales growth rate for 
three year period beginning 2002.  Sales growth will be computed by averaging the 
percentage change in actual sales volume for a three year period (2002-2004).  The 
rate of change of sales growth measures will be computed by taking the difference 
between two years and divided by the earlier year, resulting in each growth measure 
having two figures (i.e. 2002 and 2003; and 2003 and 2004).  The average sales 
growth rate is derived by dividing the total sales growth rate by two for 2002 to 2004. 
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1.8.8 Satisfaction 
Satisfaction refers to the perceived satisfaction of the entrepreneurs with their 
overall enterprise performance (Masuo, Fong, Yanagida & Cabal, 2001). 
 
1.8.9 The Entrepreneur 
The entrepreneur refers to the individual who is the founder or owner of the 
enterprise and actively manages the enterprise (Kets de Vries, 1996). 
 
1.8.10 Product 
Product refers to the output of an enterprise and includes both tangible goods 
and services (Kotler, 2003). 
 
1.8.11 Entrepreneur Characteristics 
Entrepreneur characteristics refer to entrepreneurial orientation and comprise 
of demographic factors that contribute to or detract from an individual’s ability to 
become a successful biotechnology entrepreneur. 
 
1.8.12 Entrepreneur Age 
Entrepreneur age refers to the age of an entrepreneur measured in years as 
at January 2005. 
 
1.8.13 Motivation 
Motivation determines why an enterprise is established by the entrepreneur 
and whether or not it will succeed (Lynskey, 2004a; Storey, 1994).  According to 
these two authors, the initial motivations for establishing enterprises are either based 
on positive or negative reasons.  Positive motives include, spotting a business 
opportunity; a desire to accumulate wealth; and a desire to work for oneself.  On the 
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other hand, negative motives include dissatisfaction with the existing employer; and 
the threat of unemployment and redundancy.   
 
1.8.14 Knowledge-based Resources 
Knowledge-based resources refer to intellectual capital of the entrepreneur or 
other enterprise personnels that contribute to the sustained competitive advantage of 
the enterprise in the form of educational qualification, training and experiences. 
 
1.8.15 Property-based Resources 
Property-based resources refer to property rights and controls that tie up a 
specific and well-defined asset (Miller & Shamsie, 1996).  When an enterprise has 
exclusive ownership of a valuable resource that cannot be legally imitated by rivals, it 
controls that resource.  Examples of property-based resources are enforceable long-
term contracts that monopolize scarce factors of production, embody exclusive rights 
to a valuable technology, or tie up channels of distribution. 
 
1.8.16 The Enterprise Characteristics 
The enterprise characteristics refer to the immediate setting in which SMEs 
operate. 
 
1.8.17 Enterprise Age 
Enterprise age is the age of the enterprise measured in years as at January 
2005. 
 
1.8.18 Enterprise Strategies 
Strategy may defined as major action taken or planned by the management of 
a business organisation, considering its resources, skills and environmental risks 
(Sulaiman, 1993).  
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1.8.19 Organizational Structure 
Organizational structure has been defined by Khandwalla (1977, p. 482) as 
the “network of durable and formally sanctioned organizational arrangements and 
relationships”.  Durable relationships exist between individuals in the organization, 
between individuals and machines and between work groups.  Permanent 
arrangements determine reporting mechanisms, communication patterns between 
organizational participants, job functions and rules and procedures for linking 
together the activities of individual employees.  
 
1.8.20 Organic Structure  
Organic structures are characterized by informality, decentralization of 
authority, open channels of communication and greater flexibility (Khandwalla, 1977; 
Randolph, Sapienza & Watson, 1991).   
. 
1.8.21 Mechanic Structure 
Mechanistic structures refer to structures that are highly formalized, non-
participative, hierarchical, tightly controlled and inflexible (Khandwalla, 1977; 
Randolph, Sapienza & Watson, 1991).   
 
1.8.22 Enterprise Image 
Enterprise image is defined as the overall impression, functional and 
emotional; made on the minds of customers (Hall, 1992; Schwaiger, 2004).  
According to Schwaiger (2004), the combination of functional and emotional 
components conceptualizes reputation as an attitudinal construct, where attitude 
denotes subjective, emotional, and cognitive based mindsets. Thus, evaluating 
corporate reputation not only appraises subjective perceptions of a company's 
attributes such as "successful company" and "high quality products", but also allows 
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an intrinsic disposition towards these attributes in the sense of "this company is not 
that successful, but I like it anyway", or vice versa.  
 
1.8.23 Enterprise Linkages 
Enterprise linkages refer to linkages with academic research institutions 
and/or social networking with individual researchers of the academic research 
institutions. 
 
1.8.24 Enterprise Internal and External Networking 
Networking refers to enterprise engagements with other privately owned 
enterprises in and/or outside their fields.  In this research, the term ‘joint research 
projects’ is used to differentiate productive networking that contributes to enterprise 
success from social networking. 
 
1.8.25 Vertical Integration 
Vertical integration refers to actions taken to control material resources 
(backward integration) or to control channels of distribution (forward integration) 
(Sulaiman, 1993).  It is undertaken by an enterprise as a means of strengthening the 
enterprise’s competitive position (Thomson & Strickland, 1996).  Backward 
integration offers a differentiation-based competitive advantage where an enterprise, 
by virtue of performing in-house activities that were previously outsourced, ends up 
with a better quality product or service, improves the caliber of its customer service, 
or in other ways, enhances the performance if its final product.  Forward integration, 
meanwhile, enables a manufacturing concern to integrate forward into wholesaling 
and/or retailing in order to build a committed group of dealers and outlets to better                  
represent its products to customers.  Additionally, forward integration into direct 
retailing can result in relative cost advantage and lower selling prices by eliminating 
many of the costs associated with normal wholesale-retail channels. 
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1.8.26 Innovation Activities 
Innovation is defined to encompass development of new products or services, 
new methods of production, new markets, new sources of supply and the 
reorganization of methods of operation (De Brentani, 2001; Schumpeter, 1942). 
 
1.8.27 Intensity of Competition   
Intensity of competition refers to the level of competition in price, product, 
technology, distribution, manpower and raw materials (Khandwalla, 1977; Miller, 
1987). 
 
1.9 Biotechnology 
Biotechnology may be defined in terms of the use of biological organisms for 
the attainment of commercial ends (Fransman, 1991). Biotechnology business refers 
to enterprises that use biological organisms, through various biotechnological 
techniques to develop products for human and animal healthcare, agricultural 
productivity, food processing, renewable resources, industrial and environmental 
management (BIOTEK, 2001; NPCB, 2005; Shahi, 2004). 
An unknown Hungarian engineer, Karl Eveky, first coined the term 
biotechnology in 1919 to refer to the application of technology to agricultural 
processes that can expand the world’s food supply (Smith, 1996).  In the early 
1970’s, biotechnology received a significant boost from the introduction of a number 
of powerful new technologies known as genetic engineering.  These techniques allow 
biotechnologists to alter the genetic structure of organisms by the addition of new 
genes that allow the organisms to perform new functions (Fransman, 1991).  Genetic 
engineering together with other ways of manipulating and using biological organisms 
have provided a potent new set of possibilities with profound implications for a wide 
range of commercial activities in agriculture, pharmaceuticals, chemicals, food, 
industrial processing and mining. 
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1.10 Biotechnology in Malaysia 
Biotechnology is definitely one of the fastest growing industries in the world 
and is now seen as a major area of investment by both government and private 
sectors (Ernst & Young, 2000).  It is a dynamic industry spanning many disciplines in 
science and engineering and capable of not only enhancing human health but also 
fuelling economic growth.  It has been acknowledged that biotechnology is the 
engine of growth for life sciences in the 21st century (BIOTEK, 2001) by creating 
platforms for new products and markets on many fronts (Earns & Young, 2000).  
There are five competitive advantages of biotechnology for Malaysia (Gomez, 2005).  
These are; Malaysia’s rich diversity of flora, fauna and people; the already existing 
agricultural-based biotechnology; the increasing number of government grants and 
venture capital funding; the existence of ICT infrastructure and experience in high 
technology industry;  and the government’s unrelenting commitment to  
biotechnology.  In a paper prepared by the Science Advisor Office of the Prime 
Minister Department, Malaysia (2003), it was stated that:   
Malaysia’s competitiveness and key advantage is in her vast reserves of 
million years’ old virgin rainforest and natural resources that ranges from a 
variety of flora and fauna to micro-organisms and marine heritage.  For 
example, Malaysia’s biodiversity and the traditional use of plants and herbs 
as medicines by the different cultures, provide opportunities for identifying 
useful compounds in plants and animal species that can tap into the 
estimated US$ 100 billion global pharmaceutical market. (p. 4) 
 
With its endless genetic species and diverse ecosystem, Malaysia is an 
unexplored treasure chest of medicines and useful plants and compounds (Gomez, 
2005).   
The Malaysian government has developed the Malaysian Biotechnology 
Corporation to spearhead the development of biotechnology in the country in 2005 
(MOSTI, 2005).  This corporation is aimed at being a dedicated and professional 
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one-stop agency with the main objective of developing the country’s biotechnology 
industry.  It is overseen by an Implementation Council and advised by an 
International Advisory Panel to coordinate biotechnology initiatives from all 
government ministries.  Some of its functions include; catalysing commercial spin-
offs to the private sector; facilitating market-driven R&D; and commercializing 
initiatives in agriculture, healthcare and industrial through funding and industry 
development services.   
Another recent development in biotechnology is the creation of BioNexus 
Malaysia (MOSTI, 2005).  BioNexus is essentially a network of centres of excellence 
throughout Malaysia and comprises of enterprises and institutions which specialize in 
specific biotechnology sub-sectors.  Initially, three such centres of excellence will be 
established as part of BioNexus.  The centres are; agro-biotechnology at MARDI and 
UPM, Serdang; genomic and molecular biology in UKM, Bangi; and pharmaceutical 
and nutraceuticals at Dengkil, Selangor.  In addition, Malaysia offers competitive 
financial incentives under the Promotion of Investment Acts 1986 (PIA), other pre-
packaged incentives, and various government grant programmes for biotechnology 
development in Malaysia (Mohd Osman, 2002).  
 
1.11 Malaysian Biotechnology Policy 
The National Biotechnology Policy envisions that biotechnology will be a new 
economic engine of growth for Malaysia.  The policy aims to build a favourable 
environment for R&D and industry development whilst leveraging on Malaysia’s 
already existing areas of strength.  Details of the policy is included in Appendix B. 
According to MOSTI (2005), the National Biotechnology Policy is underpinned 
by nine policy thrusts as follows: 
• Agriculture Biotechnology Development 
• Healthcare Biotechnology Development 
• Industrial Biotechnology Development 
  21
• R&D and Technology Acquisition  
• Human Capital Development 
• Financial Infrastructure Development 
• Legislative and Regulatory Framework Development 
• Strategic Positioning 
• Government Commitment 
 
1.12 Biotechnology Business 
Biotechnology business refers to “commercial activities involving biomedical; 
agricultural and veterinary; food; environmental and industrial; and other 
biotechnology related products that are associated with every aspect of human lives” 
(Shahi, 2004, p. 2).  Table 2.1 below shows the multi-faceted nature of biotechnology 
business.  
 
1.13 Biotechnology SMEs 
Biotechnology is a new industry that is knowledge-based and is 
predominantly engaged by new start-ups and small firms (Audretsch, 2001).  
According to 2001 figures from the US Biotechnology Industry Organization (BIO), 
Washington D.C., and the Biotechnology Information database (BID) maintained at 
the University of Siena, Italy; there are 2,104 dedicated biotechnology companies in 
Europe and 1,379 in the USA (Alper, 2002).  European biotechnology companies are 
on average much smaller than those in the US.  Only 10 percent of European 
biotechnology firms have more than 50 employees and over half employ fewer than 
20 people.  Nearly 70 percent of Swedish biotechnology companies employ fewer 
than 10 people, even though Sweden has a far greater percentage of companies 
created before 1991 and a larger percentage created after 1996 than do other 
European countries. 
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Table 1.2 
Areas of Biotechnology Business 
Biomedical  Food related Biotechnology 
Businesses 
 Agricultural and 
Veterinary 
 Healthcare 
 Pharmaceuticals 
 Biomedical 
biotechnology 
 Herbal and 
traditional medicine 
 Medical devices 
 Diagnostics 
 Cosmetics 
  Food processing 
 Food biotechnology 
 Food services 
  Agriculture 
 Fisheries and 
aquaculture 
 Animal 
husbandry 
 Forestry and 
lumber 
 Agro-
biotechnology 
 Recreational 
animal industry 
Environmental and 
Industrial 
 Other Biotechnology Business 
Activities 
  
 Management of 
biodiversity 
 Environmental 
bioremediation 
 Waste 
management 
 Environmental 
biotechnology 
 Marine 
biotechnology 
 Industrial 
biotechnology 
 
  Bio-IT and the application of 
information and communication 
technology in the life sciences 
 Bioengineering 
 Nanotechnologies as applied to 
the life sciences and 
biotechnology 
 Life science and biotechnology 
education 
 Life science and biotechnology 
research and development 
(R&D) 
 Life science and biotechnology 
contract services 
  
 
Source: Shahi (2004) and NPCB (2005).  
 
New technology-based firms (NTBFs) have been a key feature of growth in 
high technology development in the US and the UK (Oakey, Rothwell & Cooper, 
1988).  Morse (1976) reported that much of the growth in the high technology sphere 
in the US was provided by small firms in the 1970s.  During the 1980s, there has 
been a growing acceptance that small firms play an important role in the growth of 
high technology industries by providing a type of ‘teamwork’ driven innovation that is 
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difficult to achieve in larger enterprises (Morse, 1976; Oakey, 1984; Rothwell & 
Zegveld 1982).  Indeed, the attempts of large firms to internally replicate small firm 
attributes through various forms of ‘intrapreneurship’ are a tacit acknowledgement of 
the value of this informal small group approach to R&D and subsequent industrial 
innovation (Roberts, 1977). 
In recent years, a large number of NTBFs have been formed on the 
peripheries of universities and colleges (Dahlstrand & Klofsten, 2002).  These firms 
are considered to be very important for national and regional economic development, 
primarily as important sources of technological innovations and new job creations 
(Jones-Evans & Klofsten, 1997; Malecki, 1991).  Biotechnology is generally regarded 
as high technology which has a bearing on knowledge intensity (Daly, 1985).  In 
biotechnology, this knowledge intensity involves relationship between basic science 
and commercial activities.  According to Daly, new biotechnology firms (NBFs) in the 
US are new entrepreneurial firms formed generally since 1976 with the assistance of 
venture capital (1985).  Daly also identified that many of the firms’ founders or co-
founders were academic scientists wishing to exploit their expertise commercially in 
areas such as recombinant DNA technology (1985).  Typically these firms are 
research intensive with a high proportion of the staff involved in R&D and do not 
manufacture their own products in their early years.  Initial R&D expenses are 
financed by venture capital, through public stock offerings, contract R&D, product 
licensing and other financial mechanisms. 
As mentioned earlier in Section 1.2, the Malaysian biotechnology sector is 
also dominated by SMEs (BIC, 2001).  Currently, biotech SMEs are not clustered in 
any specific geographical location.  Most of the companies are concentrated in Kuala 
Lumpur and Selangor, while others are scattered across the country in places like 
Penang, Melaka, Johor Bahru as well as East Malaysia, in Sabah and Sarawak.  
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1.14 Summary 
Biotechnology is recently receiving greater attention from the Malaysian 
Government as reflected in the amount allocated for biotechnology programmes in 
various Malaysia Plans.  With the introduction of Malaysia Biotechnology Policy and 
various biotechnology development programmes, it is envisaged that biotechnology 
is the next engine of growth for Malaysia that will accelerate the transformation of the 
country into highly industrialized nation by the year 2020.  At this juncture, the 
success of biotechnology SMEs as major players in the sector is crucial to the rapid 
development of biotechnology for Malaysia. 
 
